Literature DB >> 6362433

Centrally induced cardiovascular and sympathetic responses to hydrocortisone in rats.

H Takahashi, K Takeda, H Ashizawa, A Inoue, S Yoneda, M Yoshimura, H Ijichi.   

Abstract

Central effects of hydrocortisone were investigated by injecting it intracerebroventricularly (icv) while recording blood pressure and heart rate in awake rats. Dose-dependent increases in both blood pressure and heart rate occurred following injections of hydrocortisone. Pretreatment by icv injections of the angiotensin II antagonist, [Sar1-Ile8]angiotensin II, completely abolished vasopressor responses to subsequent injections of hydrocortisone. When rats were later anesthetized with urethan to allow recording of abdominal sympathetic nerve activity, hydrocortisone produced vasopressor responses accompanied by corresponding increases in sympathetic nerve firing, which were also abolished by central pretreatment with either [Sar1-Ile8]angiotensin II or angiotensin I converting-enzyme inhibitor, captopril. These results indicate that centrally administered hydrocortisone stimulates the brain renin-angiotensin system to produce vasopressor responses by increasing sympathetic nerve firing.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6362433     DOI: 10.1152/ajpheart.1983.245.6.H1013

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

Review 1.  Hypothalamic and inflammatory basis of hypertension.

Authors:  Sinan Khor; Dongsheng Cai
Journal:  Clin Sci (Lond)       Date:  2017-02-01       Impact factor: 6.124

2.  Glucocorticoids act in the dorsal hindbrain to modulate baroreflex control of heart rate.

Authors:  Andrea G Bechtold; Deborah A Scheuer
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-11-03       Impact factor: 3.619

3.  Chronic activation of dorsal hindbrain corticosteroid receptors augments the arterial pressure response to acute stress.

Authors:  Deborah A Scheuer; Andrea G Bechtold; Kathy A Vernon
Journal:  Hypertension       Date:  2006-11-06       Impact factor: 10.190

4.  Chronic blockade of hindbrain glucocorticoid receptors reduces blood pressure responses to novel stress and attenuates adaptation to repeated stress.

Authors:  Andrea G Bechtold; Gina Patel; Guenther Hochhaus; Deborah A Scheuer
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-03-11       Impact factor: 3.619

5.  Determinants of daytime blood pressure in relation to obstructive sleep apnea in men.

Authors:  Jamie C M Lam; Clara S W Yan; Agnes Y K Lai; Sidney Tam; Daniel Y T Fong; Bing Lam; Mary S M Ip
Journal:  Lung       Date:  2009-08-05       Impact factor: 2.584

6.  Rapid neuromodulation by cortisol in the rat paraventricular nucleus: an in vitro study.

Authors:  Abu Zaki; R Barrett-Jolley
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

7.  Elevated corticosterone in the dorsal hindbrain increases plasma norepinephrine and neuropeptide Y, and recruits a vasopressin response to stress.

Authors:  Daisy L Daubert; Benjamin M Looney; Rebekah R Clifton; Jake N Cho; Deborah A Scheuer
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-05-14       Impact factor: 3.619

Review 8.  Regulation of the stress response in rats by central actions of glucocorticoids.

Authors:  Deborah A Scheuer
Journal:  Exp Physiol       Date:  2009-09-11       Impact factor: 2.969

Review 9.  The central mechanism underlying hypertension: a review of the roles of sodium ions, epithelial sodium channels, the renin-angiotensin-aldosterone system, oxidative stress and endogenous digitalis in the brain.

Authors:  Hakuo Takahashi; Masamichi Yoshika; Yutaka Komiyama; Masato Nishimura
Journal:  Hypertens Res       Date:  2011-08-04       Impact factor: 3.872

10.  Acute hydrocortisone administration reduces cardiovagal baroreflex sensitivity and heart rate variability in young men.

Authors:  Ahmed M Adlan; Jet J C S Veldhuijzen van Zanten; Gregory Y H Lip; Julian F R Paton; George D Kitas; James P Fisher
Journal:  J Physiol       Date:  2018-09-12       Impact factor: 5.182

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.